Novel Inhibitors to MmpL3 Transporter of Mycobacterium tuberculosis by Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulations

Novel Inhibitors to MmpL3 Transporter of Mycobacterium tuberculosis by Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulations

Bibliographic Details
Main Authors:	Hetanshi Choksi, Justin Carbone, Nicholas J. Paradis, Lucas Bennett, Candice Bui-Linh, Chun Wu
Format:	Article
Language:	English
Published:	American Chemical Society 2024-03-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.3c08401

Similar Items

Multiple Mutations in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> MmpL3 Increase Resistance to MmpL3 Inhibitors
by: Matthew B. McNeil, et al.
Published: (2020-10-01)

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth
by: Peter C. Ray, et al.
Published: (2021-01-01)

The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection
by: John T. Williams, et al.
Published: (2024-01-01)

MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis
by: Geoff Melly, et al.
Published: (2019-03-01)

Mycobacterium tuberculosis senses host Interferon-γ via the membrane protein MmpL10
by: Mohamed Ahmed, et al.
Published: (2022-12-01)

Structural & biophysical characterisation of M. tuberculosis MmpL3
by: Adams, O
Published: (2021)

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
by: Patrizia Nadia Hanieh, et al.
Published: (2022-03-01)

Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of <i>Mycobacterium smegmatis</i>: A Combined In Silico and In Vitro Study
by: Mohd Shahbaaz, et al.
Published: (2022-01-01)

Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: an emergent therapeutic target
by: Adams, O, et al.
Published: (2021)

Multi-epitope vaccine candidates based on mycobacterial membrane protein large (MmpL) proteins against Mycobacterium ulcerans
by: Tamara Z. Ishwarlall, et al.
Published: (2023-11-01)

MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
by: Su, C-C, et al.
Published: (2019)

Structure-function analysis of MmpL7-mediated lipid transport in mycobacteria
by: Nabiela Moolla, et al.
Published: (2021-12-01)

A Hydrazine–Hydrazone Adamantine Compound Shows Antimycobacterial Activity and Is a Probable Inhibitor of MmpL3
by: Julien Briffotaux, et al.
Published: (2022-10-01)

Cryo-EM structure of the trehalose monomycolate transporter, MmpL3, reconstituted into peptidiscs
by: Julie Couston, et al.
Published: (2023-01-01)

MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
by: Jigar P. Sethiya, et al.
Published: (2020-08-01)

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
by: Wei Li, et al.
Published: (2018-07-01)

Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria
by: Allison Fay, et al.
Published: (2019-06-01)

Structures of the mycobacterial membrane protein MmpL3 reveal its mechanism of lipid transport.
by: Chih-Chia Su, et al.
Published: (2021-08-01)

Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
by: Giulia Degiacomi, et al.
Published: (2020-01-01)

MmpS5-MmpL5 Transporters Provide <i>Mycobacterium smegmatis </i>Resistance to imidazo[1,2-<i>b</i>][1,2,4,5]tetrazines
by: Dmitry A. Maslov, et al.
Published: (2020-02-01)

Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption
by: Annanya Shetty, et al.
Published: (2018-12-01)

MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature
by: Mohd. Imran, et al.
Published: (2022-11-01)

Two putative MmpL homologs contribute to antimicrobial resistance and nephropathy of enterohemorrhagic E. coli O157:H7
by: Salma H. Hussein, et al.
Published: (2019-04-01)

A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis.
by: Juliane Ollinger, et al.
Published: (2019-01-01)

In vivo imaging of MmpL transporters reveals distinct subcellular locations for export of mycolic acids and non-essential trehalose polyphleates in the mycobacterial outer membrane
by: Laurie Thouvenel, et al.
Published: (2023-04-01)

Identification of Mannich Base as a Novel Inhibitor of Mycobacterium Tuberculosis Isocitrate by High-Throughput Screening
by: Lei Ji, Quanxin Long, Dacheng Yang, Jianping Xie
Published: (2011-01-01)

Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening
by: Aleix Gimeno, et al.
Published: (2021-07-01)

A high-throughput cidality screen for Mycobacterium tuberculosis.
by: Parvinder Kaur, et al.
Published: (2015-01-01)

Identification of Mycobacterium tuberculosis BioA inhibitors by using structure-based virtual screening
by: Singh S, et al.
Published: (2018-05-01)

A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitors
by: Natalia Smiejkowska, et al.
Published: (2024-03-01)

High throughput virtual screening to identify a novel inhibitor against Pyrazinamide resistant tuberculosis
by: Manaswini Jagadeb, et al.
Published: (2017-10-01)

New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis.
by: Karen G Anthony, et al.
Published: (2011-01-01)

Synthesis of Mycobacterium tuberculosis ATP synthase inhibitors
by: Pattarakiat, Seankongsuk
Published: (2022)

MYCOBACTERIUM TUBERCULOSIS STRAIN H37RV INFECTION TOWARDS MATRIX METALLOPROTEINASE (MMP)-2 IN BRAIN
by: Kevin Hartono, et al.
Published: (2017-07-01)

High throughput phenotypic analysis of Mycobacterium tuberculosis and Mycobacterium bovis strains' metabolism using biolog phenotype microarrays.
by: Bhagwati Khatri, et al.
Published: (2013-01-01)

High-throughput screen with the l,d-transpeptidase LdtMt2 of Mycobacterium tuberculosis reveals novel classes of covalently reacting inhibitors
by: de Munnik, M, et al.
Published: (2023)

Mycobacterium tuberculosis Upregulates TNF-α Expression via TLR2/ERK Signaling and Induces MMP-1 and MMP-9 Production in Human Pleural Mesothelial Cells.
by: Wei-Lin Chen, et al.
Published: (2015-01-01)

GSK-3α/β Activity Negatively Regulates MMP-1/9 Expression to Suppress Mycobacterium tuberculosis Infection
by: Xinying Zhou, et al.
Published: (2022-01-01)

Indole Inhibitors of MMP-13 for Arthritic Disorders
by: Steven J. Taylor, et al.
Published: (2021-07-01)

Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening
by: Anuradha Kumar, et al.
Published: (2022-09-01)